Droxidopa

( DrugBank: Droxidopa / KEGG DRUG: Droxidopa )


5 diseases
IDDisease name (Link within this page)Number of trials
5Progressive supranuclear palsy1
6Parkinson disease13
17Multiple system atrophy6
IDDisease name (Link within this page)Number of trials
169Menkes disease1
170Occipital horn syndrome1

5. Progressive supranuclear palsy


Clinical trials : 89Drugs : 107 - (DrugBank : 40) / Drug target genes : 65 - Drug target pathways : 108 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

6. Parkinson disease


Clinical trials : 2,307Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

17. Multiple system atrophy


Clinical trials : 119Drugs : 138 - (DrugBank : 44) / Drug target genes : 59 - Drug target pathways : 111 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

169. Menkes disease


Clinical trials : 6Drugs : 6 - (DrugBank : 4) / Drug target genes : 9 - Drug target pathways : 14 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

170. Occipital horn syndrome


Clinical trials : 2Drugs : 4 - (DrugBank : 3) / Drug target genes : 9 - Drug target pathways : 14 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries